ATE279941T1 - Nicht-virulente porphyromonas gingivalis mutante - Google Patents

Nicht-virulente porphyromonas gingivalis mutante

Info

Publication number
ATE279941T1
ATE279941T1 AT99943674T AT99943674T ATE279941T1 AT E279941 T1 ATE279941 T1 AT E279941T1 AT 99943674 T AT99943674 T AT 99943674T AT 99943674 T AT99943674 T AT 99943674T AT E279941 T1 ATE279941 T1 AT E279941T1
Authority
AT
Austria
Prior art keywords
porphyromonas gingivalis
virulent
mammal
mutant
administering
Prior art date
Application number
AT99943674T
Other languages
English (en)
Inventor
Hansel M Fletcher
Original Assignee
Univ Loma Linda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Loma Linda filed Critical Univ Loma Linda
Application granted granted Critical
Publication of ATE279941T1 publication Critical patent/ATE279941T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0216Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99943674T 1998-08-12 1999-08-11 Nicht-virulente porphyromonas gingivalis mutante ATE279941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/133,089 US6254863B1 (en) 1998-08-12 1998-08-12 Non-virulent Porphyromonas gingivalis mutant
PCT/US1999/018197 WO2000009156A1 (en) 1998-08-12 1999-08-11 Non-virulent porphyromonas gingivalis mutant

Publications (1)

Publication Number Publication Date
ATE279941T1 true ATE279941T1 (de) 2004-11-15

Family

ID=22456956

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99943674T ATE279941T1 (de) 1998-08-12 1999-08-11 Nicht-virulente porphyromonas gingivalis mutante

Country Status (7)

Country Link
US (4) US6254863B1 (de)
EP (1) EP1105156B1 (de)
AT (1) ATE279941T1 (de)
AU (1) AU761114B2 (de)
CA (1) CA2340070C (de)
DE (1) DE69921330T2 (de)
WO (1) WO2000009156A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254863B1 (en) * 1998-08-12 2001-07-03 Loma Linda University Non-virulent Porphyromonas gingivalis mutant
WO2004045550A2 (en) * 2002-11-18 2004-06-03 Boston Medical Center Corporation Immunization with porphyromonas gingivalis protects against heart disease
MXPA05008342A (es) 2003-02-06 2006-02-28 Cerus Corp Listeria atenuada para la entrada a las celulas no fagociticas, vacunas que comprenden la listeria, y metodos de uso de las mismas.
CN1758923B (zh) * 2003-02-06 2013-04-24 阿杜罗生物科技公司 进入非吞噬细胞被衰减的利斯特氏菌、含有该利斯特氏菌的疫苗
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
WO2004084936A2 (en) * 2003-02-06 2004-10-07 Cerus Corporation Modified free-living microbes, vaccine compositions and methods of use thereof
US7842289B2 (en) 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
US20060208737A1 (en) * 2005-03-16 2006-09-21 Baker Hughes Incorporated Calibration of xx, yy and zz induction tool measurements
ES2910039T3 (es) * 2015-12-15 2022-05-11 Inst Nat Sante Rech Med Vacunación contra la diabetes, la obesidad y sus complicaciones

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254863B1 (en) * 1998-08-12 2001-07-03 Loma Linda University Non-virulent Porphyromonas gingivalis mutant

Also Published As

Publication number Publication date
US20040137568A1 (en) 2004-07-15
AU5672499A (en) 2000-03-06
US6586227B2 (en) 2003-07-01
CA2340070C (en) 2003-11-11
EP1105156B1 (de) 2004-10-20
DE69921330D1 (de) 2004-11-25
US20010012512A1 (en) 2001-08-09
AU761114B2 (en) 2003-05-29
EP1105156A4 (de) 2002-07-10
WO2000009156A1 (en) 2000-02-24
CA2340070A1 (en) 2000-02-24
US6254863B1 (en) 2001-07-03
US6585977B1 (en) 2003-07-01
DE69921330T2 (de) 2006-03-09
EP1105156A1 (de) 2001-06-13
WO2000009156A9 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
AU2610799A (en) Glp-1 derivatives with helix-content exceeding 25 per cent, forming partially structured micellar-like aggregates
MY114776A (en) Fluoxetine pharmaceutical formulations
TW266228B (de)
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
GB9519661D0 (en) Fatty acid treatment
EP0954976A3 (de) Harter Kandiszucker mit verhältnismässig hohem Feuchtigkeitsgehalt und hoher Härte, und Herstellungsverfahren
ATE279941T1 (de) Nicht-virulente porphyromonas gingivalis mutante
CA2047744A1 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
PL323617A1 (en) Pharmaceutical preparation for treating oestrogen-dependent carcinomas
PT1149910E (pt) Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
DK0832186T3 (da) Erstatningsterapi til dental caries
AUPO652897A0 (en) Synthetic peptide constructs for the diagnosis and treatment of periodontitis
AU2509495A (en) Pharmaceutical formulations of cefaclor
DK0795604T3 (da) Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
BG101232A (en) Bactericides
DE69429365D1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
NO934293L (no) Fremgangsmåte og streptomycesstamme for fremstilling av antiparastiske forbindelser
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
GR3007079T3 (de)
GB9526331D0 (en) Novel method
MX9503625A (es) Metodo para reducir el daño por radicales libres en celulas de mamiferos vivos.
UA30798A (uk) Спосіб пролонгованої терапії онкологічних хворих
NO20062246L (no) Oralt immunstimulerende materiale omfattende (1-4)- bundet beta-D-mannuronsyre, samt fremgangsmate for a stimulere immunsystemet av pattedyr, fugler og krypdyr med et preparat som inneholder materialet

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties